Edition:
United States

Dignitana AB (DIGN.ST)

DIGN.ST on Stockholm Stock Exchange

19.30SEK
9 Dec 2016
Change (% chg)

0.50kr (+2.66%)
Prev Close
18.80kr
Open
19.30kr
Day's High
19.70kr
Day's Low
19.00kr
Volume
87,475
Avg. Vol
25,938
52-wk High
24.27kr
52-wk Low
14.60kr

DIGN.ST

Chart for DIGN.ST

About

Dignitana AB is a Sweden-based medical technology company. It develops, manufactures and markets a medical device primarily used for scalp cooling in order to eliminate or reduce chemotherapy induced hair loss. The Company focuses on the product DigniCap, which counteracts hair loss during chemotherapy. The product is a cold... (more)
No analyst recommendations are available for DIGN.ST.

Overall

Beta: -0.10
Market Cap(Mil.): kr391.29
Shares Outstanding(Mil.): 20.27
Dividend: --
Yield (%): --

Financials

  DIGN.ST Industry Sector
P/E (TTM): -- 30.70 30.40
EPS (TTM): -1.36 -- --
ROI: -45.64 13.28 15.24
ROE: -45.64 17.04 16.58

BRIEF-Dignitana Q3 pre-tax loss widens to SEK 7.1 million

* Q3 net sales 2.8 million Swedish crowns ($300,000) versus 529,000 crowns year ago

Nov 24 2016

BRIEF-Dignitana appoints Johan Ericsson new CEO

* Johan Ericsson new CEO of Dignitana Source text for Eikon:

Nov 10 2016

BRIEF-Dignitana receives three contracts in U.S. for Dignicap

* Said on Monday the DigniCap scalp cooling system would soon be available in 13 additional medical centers in the United States

Nov 08 2016

BRIEF-Dignitana Q2 pre-tax loss widening to SEK 7.7 million

* Q2 net sales 957,000 Swedish crowns ($113,965.20) versus 980,000 crowns year ago

Aug 25 2016

BRIEF-Dignitana: rights issue oversubscribed

* Rights issue of 19.4 million Swedish crowns ($2.3 million)oversubscribed

Jun 17 2016

Earnings vs. Estimates

No consensus analysis data available.